Related Experiment Video
Updated: Apr 19, 2026
12:27
Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
51.7K
WNT Agonist Decreases Tissue Damage and Improves Renal Function After Ischemia-Reperfusion
Michael Kuncewitch1, Weng-Lang Yang, Lana Corbo
1*Department of Surgery, Hofstra North Shore-LIJ School of Medicine; and †Center for Translational Research, The Feinstein Institute for Medical Research, Manhasset, New York.
Shock (Augusta, Ga.)
|December 17, 2014
Summary
Pharmacological activation of Wnt/β-catenin signaling using a Wnt agonist protected kidneys from ischemia-reperfusion injury (IRI). This treatment improved renal regeneration and function by reducing inflammation and oxidative stress.
Area of Science:
- Nephrology
- Molecular Biology
- Pharmacology
Background:
- Renal ischemia-reperfusion (IR) injury (IRI) is a significant clinical problem following shock or transplantation, leading to tissue damage and delayed graft function.
- The Wnt/β-catenin signaling pathway is crucial for kidney development (nephrogenesis) and may be a therapeutic target for renal protection.
Purpose of the Study:
- To investigate the protective effects of a Wnt agonist on renal IRI.
- To determine if pharmacological activation of Wnt/β-catenin signaling can mitigate kidney damage and improve function after IR.
Main Methods:
- Adult male rats underwent bilateral renal pedicle clamping for 60 minutes followed by reperfusion.
- A Wnt agonist or vehicle was administered intravenously 1 hour before ischemia.
- Renal tissues and blood were collected 24 hours post-IR for histological, molecular, and biochemical analyses.
Main Results:
- The Wnt agonist restored reduced levels of β-catenin and cyclin D1, enhanced cell proliferation (Ki67), and preserved renal histological architecture.
- Treatment significantly lowered serum creatinine, AST, and LDH levels, and inhibited inflammatory markers (IL-6, IL-1β, MPO).
- The Wnt agonist reduced markers of oxidative stress, including inducible nitric oxide synthase, nitrotyrosine, and 4-hydroxynonenal.
Conclusions:
- Pharmacological activation of Wnt/β-catenin signaling with a Wnt agonist effectively protects kidneys against IRI.
- This approach improves renal regeneration and function by attenuating inflammation and oxidative stress, offering a potential therapeutic strategy for preventing renal IRI.
